CIK 0001892443
IIMWX Bluerock High Income Institutional Credit Fund
Insider trading from SEC Form 4. Last filing 9 d ago.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
4
with a Form 4 at this company
Signals
Open-market buys and sells at Bluerock High Income Institutional Credit Fund, scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 8 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | I. Bobby Majumder other | JOther Common Shares of Beneficial Interest | +56 | $22.33 | $1,250 | 1,092 | 9 d ago |
| Oct 1, 2026 | Romano Tio other | JOther Common Shares of Beneficial Interest | +56 | $22.33 | $1,250 | 1,092 | 9 d ago |
| Oct 1, 2026 | Kamal Jafarnia other | JOther Common Shares of Beneficial Interest | +56 | $22.33 | $1,250 | 1,092 | 9 d ago |
| Oct 1, 2026 | Sohaila Sori Farsheed other | JOther Common Shares of Beneficial Interest | +56 | $22.33 | $1,250 | 1,092 | 9 d ago |
| Dec 31, 2024 | I. Bobby Majumder other | JOther Shares of Beneficial Interest, Class I Shares | +53 | $23.74 | $1,250 | 603 | Jan 8, 2025 |
| Dec 31, 2024 | Romano Tio other | JOther Shares of Beneficial Interest, Class I Shares | +53 | $23.74 | $1,250 | 603 | Jan 8, 2025 |
| Dec 31, 2024 | Kamal Jafarnia other | JOther Shares of Beneficial Interest, Class I Shares | +53 | $23.74 | $1,250 | 603 | Jan 8, 2025 |
| Dec 31, 2024 | Sohaila Sori Farsheed other | JOther Shares of Beneficial Interest, Class I Shares | +53 | $23.74 | $1,250 | 603 | Jan 8, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Sohaila Sori Farsheedother
- Kamal Jafarniaother, director
- I. Bobby Majumderother, director
- Romano Tioother, director
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.